Association of the metastatic phenotype with CCN family members among breast and oral cancer cells

Journal of Cell Communication and Signaling

Volumn 5, Issue 4, 2011, Pages 291-299

  Ohgawara, Toshihiro ^a   Kubota, Satoshi ^a   Kawaki, Harumi ^a   Kurio, Naito ^a   Abd El Kader, Tarek ^a   Hoshijima, Mitsuhiro ^a   Janune, Danilo ^a   Shimo, Tsuyoshi ^a   Perbal, Bernard ^b   Sasaki, Akira ^a   Takigawa, Masaharu ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Bone metastasis; Breast cancer; CCN family; CCN2; CCN3; Oral cancer

Indexed keywords

CCN PROTEIN; CONNECTIVE TISSUE GROWTH FACTOR; NEPHROBLASTOMA OVEREXPRESSED PROTEIN;

ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER CELL; CANCER INVASION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; HUMAN; HUMAN CELL; METASTASIS; MOUTH CANCER; PHENOTYPE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

EID: 85027936687     PISSN: 18739601     EISSN: 1873961X     Source Type: Journal    
DOI: 10.1007/s12079-011-0133-3     Document Type: Article

References (28)

1. Babic AM, Kireeva ML, Kolesnikova TV, Lau LF (1998) CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. Proc Natl Acad Sci USA 95:6355-6360 (Pubitemid 28249016)
2. Brigstock DR (2003) The CCN family: a new stimulus package. J Endocrinol 178:169-175 (Pubitemid 37063059)
3. Chen CC, Lau LF (2009) Functions and mechanisms of action of CCN matricellular proteins. Int J Biochem Cell Biol 41:771-783
4. Espinoza I, Liu H, Busby R, Lupu R (2011). CCN1 a candidate target for zoledronic acid treatment in breast cancer. Mol Cancer Ther in press
5. Fritah A, Saucier C, De Wever O, Bracke M, Bièche I, Lidereau R, Gespach C, Drouot S, Redeuilh G (2008) Role of WISP-2/CCN5 in the maintenance of a differentiated and noninvasive phenotype in human breast cancer cells. Mol Cell Biol 28:1114-1123 (Pubitemid 351160067)
6. Guise TA, Mundy GR (1998) Cancer and bone. Endocr Rev 19:18-54 (Pubitemid 29122073)
7. Jiang WG, Watkins G, Fodstad O, Douglas-Jones A, Mokbel K, Mansel RE (2004) Differential expression of the CCN family members Cyr61, CTGF and Nov. in human breast cancer. Endcr Relat Cancer 11:781-791 (Pubitemid 40065551)
8. Kang Y, Siegel P, Shu W, Drobnjak M, Kakonen SM, Cordón-Cardo C, Guise TA, Massagué J (2003) A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 5:537-549 (Pubitemid 36808649)
9. Kawaki H, Kubota S, Minato M, Moritani NH, Hattori T, Hanagata H, Kubota M, Miyauchi A, Nakanishi T, Takigawa M (2003) Novel enzyme-linked immunosorbent assay systems for the quantitative analysis of connective tissue growth factor (CTGF/Hcs24/CCN2): detection of HTLV-1 tax-induced CTGF from a human carcinoma cell line. DNA Cell Biol 22:641-648 (Pubitemid 37357734)
10. Kawaki H, Kubota S, Suzuki A, Yamada T, Matsumura T, Mandai T, Yao M, Maeda T, Lyons KM, Takigawa M (2008a) Functional requirement of CCN2 for intramembranous bone formation in embryonic mice. Biochem Biophys Res Commun 366:450-456 (Pubitemid 50017002)
11. Kawaki H, Kubota S, Suzuki A, Lazar N, Yamada T, Matsumura T, Ohgawara T, Maeda T, Perbal B, Lyons KM, Takigawa M (2008b) Cooperative regulation of chondrocyte differentiation by CCN2 and CCN3 shown by a comprehensive analysis of the CCN family proteins in cartilage. J Bone Miner Res 23:1751-1764
12. Kubota S, Takigawa M (2007) Role of CCN2/CTGF/Hcs24 in bone growth. Int Rev Cytol 257:1-41 (Pubitemid 46186474)
13. Kubota S, Takigawa M (2011). The role of CCN2 in cartilage and bone development. J Cell Commun Signal in press
14. Kubota S, Kawata K, Yanagita T, Doi H, Kitoh T, Takigawa M (2004) Abundant retention and release of connective tissue growth factor (CTGF/CCN2) by platelets. J Biochem 136:279-282 (Pubitemid 39545786)
15. Leask A (2011). Possible strategies for anti-fibrotic drug intervention in scleroderma. J Cell Commun Signal in press
16. Leask A, Abraham DJ (2006) All in the CCN family: essential matricellular signaling modulators emerge from the bunker. J Cell Sci 119:4803-4810 (Pubitemid 46017793)
17. Lin CG, Leu SJ, Chen N, Tebeau CM, Lin SX, Yeung CY, Lau LF (2003) CCN3 (NOV) is a novel angiogenic regulator of the CCN protein family. J Biol Chem 278:24200-24208 (Pubitemid 36830256)
18. Menendez JA, Vellon L, Mehmi I, Teng PK, Griggs DW, Lupu R (2005) A novel CYR61-triggered 'CYR61-alphavbeta3 integrin loop' regulates breast cancer cell survival and chemosensitivity through activation of ERK1/ERK2 MAPK signaling pathway. Oncogene 2005(24):761-779 (Pubitemid 40216085)
19. Nakanishi T, Nishida T, Shimo T, Kobayashi K, Kubo T, Tamatani T, Tezuka K, Takigawa M (2000) Effect of CTGF/Hcs24, a product of a hypertrophic chondrocyte-specific gene, on the proliferation and differentiation of chondrocytes in culture. Endocrinology 141:264-273 (Pubitemid 32260367)
20. Perbal B (2004) CCN proteins: multifunctional signalling regulators. Lancet 363:62-64 (Pubitemid 38076928)
21. Perbal B, Takigawa M (2005) CCN proteins: a new family of cell growth and differentiation regulators. Imperial College Press, London
22. Sasaki A, Boyce BF, Story B, Wright KR, Chapman M, Boyce R, Mundy GR, Yoneda T (1995) Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice. Cancer Res 55:3551-3557
23. Shimo T, Nakanishi T, Nishida T, Asano M, Kanyama M, Kuboki T, Tamatani T, Tezuka K, Takemura M, Matsumura T, Takigawa M (1999) Connective tissue growth factor induces the proliferation, migration, and tube formation of vascular endothelial cells in vitro, and angiogenesis in vivo. J Biochem (Tokyo) 126:137-145 (Pubitemid 29355403)
24. Shimo T, Kubota S, Yoshioka N, Ibaragi S, Isowa S, Eguchi T, Sasaki A, Takigawa M (2006) Pathogenic role of connective tissue growth factor (CTGF/CCN2) in osteolytic metastasis of breast cancer. J Bone Miner Res 21:1045-1059 (Pubitemid 43962833)
25. Tsai MS, Bogart DF, Castañeda JM, Li P, Lupu R (2002) Cyr61 promotes breast tumorigenesis and cancer progression. Oncogene 21:817881-817885
26. Xie D, Nakachi K, Wang H, Elashoff R, Koeffler HP (2001) Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features. Cancer Res 61:8917-8923 (Pubitemid 34013909)
27. Yanagita T, Kubota S, Kawaki H, Kawata K, Kondo S, Takano-Yamamoto T, Tanaka S, Takigawa M (2007) Expression and physiological role of CCN4/Wnt-induced secreted protein 1 mRNA splicing variants in chondrocytes. FEBS J 274:1655-1665 (Pubitemid 46426900)
28. Yoneda T (1998) Cellular and molecular mechanisms of breast and prostate cancer metastasis to bone. Eur J Cancer 34:240-245